Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
05/2010
05/26/2010CN101129748B Proprietary Chinese medicine for treating cancer of the lungs and method of preparing the same
05/26/2010CN101125159B Medicine for treating hemorrhoid, anal fissure and anal fistula
05/26/2010CN101120977B Medicine for treating tumor
05/26/2010CN101099814B Medicinal composition for delaying male senility
05/26/2010CN101099762B Blood pressue lowering sustained-release preparation with chrysanthemum flower and pearl
05/26/2010CN101095688B Application of mannose in the preparation of medicine for treating pulmonary inflammation disease
05/26/2010CN101066258B Inclusion compound of higher fatty alcohol and its preparation
05/26/2010CN101062377B Adhesive plaster for diminishing inflammation, expelling wind and cold
05/26/2010CN101062260B Granule for complementing Yin and preventing anxiety and its production method
05/26/2010CN101062233B Powdered medicine for coaptation and its preparing process
05/26/2010CN101062210B Chinese medicine for treating bone disease
05/26/2010CN101045134B Method for preparing medicine to treat atherosclerosis
05/26/2010CN101045051B Novel use of tizanidine or its derivatives in preparing medicine for prolonging fast wave sleep
05/26/2010CN101040847B Nanometer medicine agent produced by hydrogenated castor oil and the technique of preparing the same
05/26/2010CN101032531B Hyperfine Chinese traditional medicine pieces taken with or without water and the preparing method
05/26/2010CN101032484B Capsule type tiotropium bromide inhalation powder
05/26/2010CN101028281B Nano-gel pectin bismuth and its granules medicine
05/26/2010CN101020027B Medicine composition for preventing and treating AIDS and its preparation process and use
05/26/2010CN101019836B Nanometer cytochrome liposome medicine and its preparation
05/26/2010CN101015648B Use of succinic acid derivative eater compound for treating dementia
05/25/2010US7725329 System and method for automatic generation of a hierarchical tree network and the use of two complementary learning algorithms, optimized for each leaf of the hierarchical tree network
05/25/2010US7725026 Phase responsive optical fiber sensor
05/25/2010US7723500 Containing unmethylated CpG dinucleotides; redirection of a Th2 response to a Th1 response; atopic diseases, dermatitis; booster vaccines
05/25/2010US7723467 Antimicrobial compounds
05/25/2010US7723390 Thyroid hormones or their salts in capsule or in swallowable uniform soft-gel gelatin matrices for treatment of hypothyroidism
05/25/2010US7723379 Dosage form of polysaccharides, especially cocoa extracts, containing procyanidine units an additional nitric oxide modulating agent; dietary supplements; pet foods
05/25/2010US7723361 Kaposi's sarcoma; Crohn's disease; combination therapy with an epoxide hydrolase inhibitor
05/25/2010US7723344 Dipeptidyl peptidase inhibitors
05/25/2010US7723320 Use of estrogen compounds to increase libido in women
05/25/2010US7723311 Delivery of bioactive substances to target cells
05/25/2010US7723310 increasing patient compliance in treatment of hepatitis-C virus infection
05/25/2010US7723306 such as glucosyl and maltosyl sucrose; storage stability
05/25/2010US7723304 Hypotensive agents; cardiovascular disorders; wound healing agents; antitumor agents; antidiabetic agents ; nephropathy; gastrointestinal disorders; alopecia; blood disorders ; urogenital disorders
05/25/2010US7723091 combination of a mannanase and a carrier that is adapted for oral administration and does not contain an anti-infection agent other than the mannanase; treating or ameliorating the risk of a digestive tract infection, particularly of Eimeria, Cryptosporidium, or Clostridium
05/25/2010US7723087 Preparing transgenic microorganism comprising modified intercellular adhesion (ica) locus and which generates cell surface proteins with altered poly-N-acetyl glucosamine (PNAG) side chain profile for use in vaccine development; bactericides
05/25/2010US7723056 Particles
05/25/2010US7723035 detecting a reduction in gene copy number, by determining gene mutational status, or by detecting a reduction in the RNA transcribed from these genes; inhibition of neoplastic or tumorigenic growth of cancers such as chronic lymphocytic leukemia or prostate cancer cells
05/25/2010US7723022 Oligonucleotide containing activated lymphocytes; antibody therap y; skin disorders; antiallergens; respiratory system disorders
05/25/2010US7722899 Surface-treated powder and cosmetic preparation
05/25/2010US7722898 Modified-release preparations containing oxcarbazepine and derivatives thereof
05/25/2010US7722896 Biocompatible polyarylates of diphenol compounds and poly(alkylene oxide) dicarboxylic acids, articles formed therefrom and therapeutic uses are disclosed.
05/25/2010US7722891 Multiple emulsions
05/25/2010US7722696 Coated granular substances
05/25/2010US7722598 Apparatus and system for delivery of drug therapies
05/25/2010CA2582666C Controlled release implant
05/25/2010CA2577589C Vascular embolus of paclitaxel-sodium alginate microsphere and its preparation
05/25/2010CA2441352C Liquid formulations for the prevention and treatment of mucosal diseases and disorders
05/25/2010CA2440763C Liquid formations for electrohydrodymanic spraying containing polymer and suspended particles
05/25/2010CA2434961C L-histidine in ophthalmic solutions
05/25/2010CA2426263C Nateglinide-containing preparation
05/25/2010CA2420523C Controlled and sustained release properties of polyelectrolyte multilayer capsules
05/25/2010CA2419825C Hard capsule made from a polymer or copolymer formed by polymerizing at least one polymerizable vinyl monomer in the presence of polyvinylalcohol or a derivative thereof
05/25/2010CA2407079C Fluid material dispensing syringe
05/25/2010CA2400444C Medical adhesive composition, medical adhesive tape using the same and tape preparation for percutaneous absorption
05/25/2010CA2394471C External preparation for treating pruritus
05/25/2010CA2375923C Devices and compounds for treating arterial restenosis
05/25/2010CA2375727C Cytofectin dimers and methods of use thereof
05/25/2010CA2368621C Methods and compositions for treating solid tumors
05/25/2010CA2361573C Biodegradable glass compositions and methods for radiation therapy
05/25/2010CA2342121C Powdered mannitol and the procedure for preparing it
05/25/2010CA2330237C Broad specificity dna damage endonuclease
05/25/2010CA2310147C Spheroids, preparation method and pharmaceutical compositions
05/25/2010CA2290805C Powdered sorbitol and its preparation
05/25/2010CA2199715C Novel implant and novel vector for the treatment of acquired diseases
05/20/2010WO2010057215A1 Engineering porous particles of water soluble therapeutics for pressurized metered-dose inhaler formulations
05/20/2010WO2010057214A2 Nanoparticles and porous particles and methods of making the same
05/20/2010WO2010057189A1 Transdermal systems containing multilayer adhesive matrices to modify drug delivery
05/20/2010WO2010057188A2 Fast-acting, dietary supplement containing compositions and methods of producing the compositions
05/20/2010WO2010057160A1 Releasable fusogenic lipids for nucleic acids delivery systems
05/20/2010WO2010057140A1 Dental appliance cleanser
05/20/2010WO2010057117A2 Topical transdermal drug delivery compositions
05/20/2010WO2010057036A2 Solid composition for controlled release of ionizable active agents with poor aqueous solubility at low ph and methods of use thereof
05/20/2010WO2010057034A1 Compositions and methods for alleviating hyposalivation and for providing oral comfort
05/20/2010WO2010057007A1 Organogel compositions and processes for producing
05/20/2010WO2010056957A1 Controlled release food formulations
05/20/2010WO2010056847A2 Lyophilization formulation
05/20/2010WO2010056754A2 Inhibition of mammalian target of rapamycin
05/20/2010WO2010056598A2 Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof
05/20/2010WO2010056216A1 Pharmaceutical composition comprising ibuprofen, pseudoephedrine and chlorpheniramine
05/20/2010WO2010056065A2 Method for preparing microspheres and microspheres produced thereby
05/20/2010WO2010056039A2 Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability
05/20/2010WO2010055974A1 Composition for preventing and treating diabetes and metabolic syndrome disorders containing obovatol and derivatives thereof as active ingredients
05/20/2010WO2010055963A1 Manufacturing method of acetate-free dialysate composition
05/20/2010WO2010055950A1 Novel cancer targeting therapy using complex of substance capable of binding specifically to constituent factor of cancer stroma and anti-tumor compound
05/20/2010WO2010055929A1 Novel hsp90-targeted anti-cancer chimeric peptide
05/20/2010WO2010055622A1 Simple device for treating trichophytosis unguium
05/20/2010WO2010055416A1 Dispersion and debundling of carbon nanotubes using gemini surfactant compounds
05/20/2010WO2010055304A2 Pharmaceutical compounds
05/20/2010WO2010055268A1 Novel method for preparing granulates of active principles, and granulates obtained thereof
05/20/2010WO2010055260A1 Novel composition based on gamma-hydroxybutyric acid
05/20/2010WO2010055252A2 Plant-based granules
05/20/2010WO2010055119A2 Pharmaceutical composition comprising pimobendan
05/20/2010WO2010054845A1 Improved dissolution stability of calcium carbonate tablets
05/20/2010WO2010054833A1 Intermediate and oral administrative formats containing lenalidomide
05/20/2010WO2010054654A1 Modified cationic liposome adjuvans
05/20/2010WO2010054533A1 Cyproheptadine hydrochloride cream and preparation method thereof
05/20/2010WO2010054507A1 Inclusion complexes of pinocembrin with cyclodextrin or its derivatives
05/20/2010WO2010054495A2 Non-aqueous colloidal formulation
05/20/2010WO2010054446A1 Combination of two or more peptides in a single stable lyophilized pharmaceutical compound
05/20/2010WO2010035268A3 Device for photodynamical therapy of cancer